Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dansac medical AB
AB
Active
Org 5593661902
Nytorpsvägen 6
General medical practice activities · NACE 8621
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1M
+1277% vs 2023
EBITDA margin
96.7%
+1640% vs 2023
Equity ratio
63.8%
Financial strength
Net profit 2024
SEK 787K
+1569% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2022
0M
0%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
SEK 1M
+1277%
EBITDA
SEK 980K
+1640%
Net profit
SEK 787K
+1569%
Total assets
SEK 1,3M
+594%
Equity
SEK 819K
+704%
Employees
0
—
Company information
Legal name
Dansac medical AB
Org number
5593661902
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 februari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska sälja tjänster inom hälsa och sjukvård.
Contact
Address
Nytorpsvägen 6
Email
dansacmedical@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Eskilstuna
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
1M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
289
74
1 013
Staff expenses
−5
−3
−20
EBITDA
274
56
980
Depreciation & amort.
—
—
—
EBIT
274
56
980
Net financials
0
3
9
Profit before tax
274
59
989
Tax
−56
−12
−202
Net profit
217
47
787
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
369
185
1 284
Equity
242
102
819
Long-term debt
—
—
—
Short-term debt
127
83
465
Total debt
127
83
465
Financial ratios
5-year trend
EBITDA margin
96.7%
This company
15.8%
Market median
+512% vs market
2022
2024
Equity ratio
63.8%
This company
38.2%
Market median
+67% vs market
2022
2024
Return on equity
96.1%
This company
18.4%
Market median
+422% vs market
2022
2024
Net profit margin
77.7%
This company
8.1%
Market median
+859% vs market
2022
2024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
2022
2024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-02-17 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AH
Anna Helena Nee
Authorized Recipient of Service
Authorized Recipient of Service
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AB
Arie Benoit Dansac
Board of Directors
2022
AP
Ana Paulina Navarrete Trejo
Deputy Board Member
2022
Former (1)
KK
Konstantinos Kontogiannis
Deputy Board Member
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dansac medical AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Helena Nee
Authorized Recipient of Service
0 companies
Arie Benoit Dansac
Board of Directors
0 companies
Ana Paulina Navarrete Trejo
Deputy Board Member
0 companies
Konstantinos Kontogiannis
Deputy Board Member
0 companies